Li, M., Jiang, L., Zhang, M., Liu, S., Sawh, R. R., Zheng, J., . . . Wang, B. (2023). Elevated serum FGF21 is an independent predictor for adverse events in hemodialysis patients from two large centers: A prospective cohort study. Renal Failure, 45(2), 1. https://doi.org/10.1080/0886022X.2023.2256414
Chicago Style (17th ed.) CitationLi, Min, et al. "Elevated Serum FGF21 Is an Independent Predictor for Adverse Events in Hemodialysis Patients from Two Large Centers: A Prospective Cohort Study." Renal Failure 45, no. 2 (2023): 1. https://doi.org/10.1080/0886022X.2023.2256414.
MLA (9th ed.) CitationLi, Min, et al. "Elevated Serum FGF21 Is an Independent Predictor for Adverse Events in Hemodialysis Patients from Two Large Centers: A Prospective Cohort Study." Renal Failure, vol. 45, no. 2, 2023, p. 1, https://doi.org/10.1080/0886022X.2023.2256414.